reimbursement — 17 things I got wrong before I got it right
The title is the argument: reimbursement — 17 things I got wrong before I got it right. Here is the rest of it.
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.
Would rather be corrected in public than confident in private.
best — the order this archive was captured in
Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.
The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.
Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.
Country added to the title — the answers differ across the union and the thread is unusable without it.
This. The published reimbursement criteria are the document to read, and most member states do publish them.
Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.
Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.
reimbursement is national, not European, and that is the whole board
pack sizes differ, so per-month comparisons need care
Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.
Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.
Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.
the reimbursement criteria are published in most member states
The structure that makes this board make sense, once.
Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that — whether it is reimbursed, on what criteria, at what price, in what pack size, dispensed under what margin rules — is decided nationally.
So "is it covered" has twenty-seven answers, "what does it cost" has twenty-seven answers plus within-country variation, and only "is it authorised" has one. Almost every argument on this board is two people answering different questions from different countries, both correctly.
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
What pack size is that price for?
What does the local patient information leaflet say?
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
That shortage notice was national and does not apply where the question is coming from.
Right, and a shortage notice in one country tells you very little about the next one along.
Is this a cross-border question or a domestic one?
- 1The structure that makes this board make sense, once. Marketing…8 comments in this branch · started by u/gastric_emptying_g
- 2Read the published reimbursement criteria where I live rather than asking.…7 comments in this branch · started by u/nikhil_asante